Wee Leng
Procalcitonin (PCT) has emerged as a significant biomarker for bacterial infections and has shown potential in guiding antibiotic therapy, particularly within the context of antimicrobial stewardship programs. This article explores the role of procalcitonin in hospitalized patients with seasonal influenza, focusing on its utility as an antimicrobial stewardship tool. By analyzing the current literature, this study investigates how PCT levels can differentiate between bacterial and viral infections, thereby optimizing antibiotic use, reducing unnecessary prescriptions, and ultimately combating antibiotic resistance. The findings indicate that PCT-guided therapy can effectively improve patient outcomes, decrease hospital costs, and support the global initiative for responsible antibiotic use.
ఈ కథనాన్ని భాగస్వామ్యం చేయండి
English 
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 